Showing 1 - 6 results of 6 for search 'V. A. Rogov', query time: 0.01s Refine Results
  1. 1
    PHARMACOECONOMIC STUDY OF LENVIMA (LENVATINIB) IN ADVANCED PROGRESSIVE RADIO IODINE REFRACTORY DIFFERENTIATED THYROID CANCER IN THE RUSSIAN FEDERATION

    PHARMACOECONOMIC STUDY OF LENVIMA (LENVATINIB) IN ADVANCED PROGRESSIVE RADIO IODINE REFRACTORY DIFFERENTIATED THYROID CANCER IN THE RUSSIAN FEDERATION by M. Yu. Frolov, V. A. Rogov

    Published 2016-04-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    EVALUATION OF DRUG THERAPY IN PROGRESSING DIFFERENTIATED THYROID CANCER REFRACTORY TO RADIOACTIVE IODINE IN PATIENTS RESIDING IN THE RUSSIAN FEDERATION : PHARMACOECONOMIC ASPECTS

    EVALUATION OF DRUG THERAPY IN PROGRESSING DIFFERENTIATED THYROID CANCER REFRACTORY TO RADIOACTIVE IODINE IN PATIENTS RESIDING IN THE RUSSIAN FEDERATION : PHARMACOECONOMIC ASPECTS by M. Yu. Frolov, V. A. Rogov

    Published 2017-05-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    PHARMACOECONOMIC JUSTIFICATION OF A WIDER USE OF PREVENTIVE HEMOPHILIA THERAPY IN THE RUSSIAN FEDERATION

    PHARMACOECONOMIC JUSTIFICATION OF A WIDER USE OF PREVENTIVE HEMOPHILIA THERAPY IN THE RUSSIAN FEDERATION by M. Yu. Frolov, V. A. Rogov

    Published 2018-02-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Evaluation of the economic effect of biological therapy in patients with severe COVID-19 and cytokine storm

    Evaluation of the economic effect of biological therapy in patients with severe COVID-19 and cytokine storm by M. Yu. Frolov, A. S. Salasyuk, V. A. Rogov

    Published 2021-02-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Clinical and economic benefits of using sonidegib in the 1-line therapy of patients with locally advanced basal cell carcinoma

    Clinical and economic benefits of using sonidegib in the 1-line therapy of patients with locally advanced basal cell carcinoma by O. I. Ivakhnenko, V. V. Ryazhenov, M. Yu. Frolov, V. A. Rogov

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Cost-effectiveness analysis of active psoriatic arthritis treatment with ixekizumab in adult patients in Russian Federation health care system

    Cost-effectiveness analysis of active psoriatic arthritis treatment with ixekizumab in adult patients in Russian Federation health care system by E. A. Pyadushkina, E. V. Derkach, M. Yu. Frolov, V. A. Rogov, A. S. Salasyuk

    Published 2021-02-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: